These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 6383323

  • 1. Chronic bacterial infection models for BRM screening.
    Dickneite G, Schorlemmer HU, Sedlacek HH.
    Behring Inst Mitt; 1984 May; (74):174-82. PubMed ID: 6383323
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU, Bosslet K, Sedlacek HH.
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunopotentiation in infectious disease, II. Effect of bestatin on experimental infection.
    Ormrod DJ, Clarke IA, Miller TE.
    Chemioterapia; 1985 Aug; 4(4):324-8. PubMed ID: 3902258
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
    Barchielli M, Coppi G.
    Acta Physiol Hung; 1990 Aug; 75 Suppl():25-6. PubMed ID: 2371881
    [No Abstract] [Full Text] [Related]

  • 18. The NCI preclinical screen of biological response modifiers.
    Talmadge JE, Fidler IJ, Oldham RK.
    Behring Inst Mitt; 1984 May; (74):189-94. PubMed ID: 6206841
    [Abstract] [Full Text] [Related]

  • 19. Induction of anti-Escherichia coli activity in mice by phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N, Sakagami H, Komatsu N, Fujimaki M, Wada C, Molnar J.
    In Vivo; 1992 May; 6(6):585-8. PubMed ID: 1296806
    [Abstract] [Full Text] [Related]

  • 20. Urinary immunoglobulin excretion in induced urinary infection.
    Uehling DT.
    Invest Urol; 1972 Mar; 9(5):408-10. PubMed ID: 4552604
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.